FC
VERA icon

FORA Capital’s Vera Therapeutics VERA Stock Holding History

FORA Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,074
Closed -$206K – 608
2025
Q4 		$206K Buy
+4,074
New +$145K 0.02% 395
2024
Q4 		– Sell
-10,622
Closed -$469K – 601
2024
Q3 		$469K Sell
10,622
-2,352
-18% -$89.3K 0.06% 293
2024
Q2 		$469K Sell
12,974
-3,084
-19% -$122K 0.06% 299
2024
Q1 		$692K Buy
+16,058
New +$572K 0.06% 281

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FORA Capital's VERA Position: Q1 2026 in Review

FORA Capital sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 4,074 shares — an estimated $206K sold.

FORA Capital first reported a position in VERA in Q1 2024 and held it in 4 quarters. The position peaked at $692K in Q1 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • FORA Capital reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 4,074 Vera Therapeutics shares in Q1 2026, an estimated $206K.
  • FORA Capital first reported a position in Vera Therapeutics in Q1 2024 and held it in 4 quarters.
  • FORA Capital's Vera Therapeutics position peaked at $692K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.